drugset / Trial / NCT01361529
Safety Study of FLP Injection to Treat Tumor Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the tolerance and maximum tolerated dose (MTD) for FLP Injection with multiple dose in tumor patients.
Timeline
- Start
- 2009-06
- Primary completion
- 2011-06
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FLP | Unknown | 93 mg/m2 | — |
| Subject | FLP | Unknown | 331 mg/m2 | — |
Indications
No indication recorded.